Association of Diastolic Dysfunction with Angiographic Severity of Coronary Artery Disease in patients with Non-ST

J Farjana1, M A Rahman, M M Rahman

  • 1Dr Jinat Farjana, MD, Department of Cardiology, National Institute of Cardiovascular Diseases (NICVD), Dhaka, Bangladesh;

Insights

Left ventricular diastolic dysfunction (LVDD) is linked to more severe coronary artery disease (CAD) in non-ST elevation myocardial infarction (NSTEMI) patients. This finding highlights LVDD as a marker for advanced CAD severity.

Area of Science:

  • Cardiology
  • Diagnostic Imaging
  • Internal Medicine

Background:

  • Left ventricular diastolic dysfunction (LVDD) is an evolving clinical concern.
  • LVDD presence signifies a poor prognosis in patients with acute coronary syndrome (ACS) and chronic coronary artery diseases (CAD).
  • Understanding the association between LVDD and CAD severity in non-ST elevation myocardial infarction (NSTEMI) is crucial for patient outcomes.

Purpose of the Study:

  • To evaluate the association between LVDD and the angiographic severity of CAD.
  • To investigate this association specifically in patients diagnosed with NSTEMI.

Main Methods:

  • A cross-sectional analytical study involving 120 NSTEMI patients undergoing coronary angiography (CAG).
  • Transthoracic echocardiography was performed to establish the presence or absence of LVDD.
  • CAD severity was assessed using Vessel score and Leaman score.

Main Results:

  • A significantly higher prevalence of positive Leaman scores (95.4%) was observed in patients with LVDD compared to those without (63.6%, p<0.001).
  • Patients with LVDD showed a higher proportion of multi-vessel involvement (72.6%) compared to single-vessel involvement.
  • A positive correlation was found between LVDD and CAD severity, with higher grades of diastolic dysfunction associated with more severe vessel and Leaman scores.

Conclusions:

  • Left ventricular diastolic dysfunction (LVDD) is associated with angiographically severe coronary artery disease (CAD) in patients presenting with non-ST elevation myocardial infarction (NSTEMI).
  • LVDD serves as an indicator of more advanced CAD, suggesting its importance in risk stratification and management of NSTEMI patients.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
20
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
43
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
53
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
24
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
32